Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Challenges of Compounding for Patients on the Ketogenic Diet

Author(s):  McElhiney Linda F

Issue:  Mar/Apr 2007 - Diabetes
View All Articles in Issue

Page(s):  116-120

Challenges of Compounding for Patients on the Ketogenic Diet Page 1
Challenges of Compounding for Patients on the Ketogenic Diet Page 2
Challenges of Compounding for Patients on the Ketogenic Diet Page 3
Challenges of Compounding for Patients on the Ketogenic Diet Page 4
Challenges of Compounding for Patients on the Ketogenic Diet Page 5

Download in electronic PDF format for $75

Abstract:  A child on a ketogenic diet is a classic example of a patient who cannot take commercially available drug products. The ketogenic diet is a treatment option for young children who have catastrophic, intractable epilepsy or inborn metabolic defects involving glucose metabolism. Most children stay on the diet for 2 to 3 years and must be monitored by a team of healthcare professionals consisting of neurologists, nurses, dieticians, and pharmacists. The ketogenic diet is a high-fat, low-carbohydrate, and low-protein diet designed to increase the body’s dependence on fatty acids for energy rather than glucose. The calculations of daily allowances of protein, fat, and carbohydrates must be exact. Compounding pharmacists assist the caregivers or patients and their dieticians by preparing medications whose carbohydrate content is calculated exactly.

Related Keywords: epilepsy, children, ketogenic diet, seizure disorder, dietary fats, dietary lipids, carbohydrates, vehicles, sweeteners, formulations, excipients


Printer-Friendly Version

Related Articles from IJPC
(Click for Abstract / Details / Purchase)
Challenges of Compounding for Patients on the Ketogenic Diet
McElhiney Linda F
Mar/Apr 2007
Pg. 116-120

Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet
McElhiney Linda F
, Cheng Angela, Meshberger Laura, Imai Lara
Jan/Feb 2010
Pg. 21-25

Feline Urologic Syndrome and Diet Formulation
Long Scott F
Sep/Oct 1999
Pg. 366-367

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Oral Liquid Vehicles, Featured Excipient:
Allen Loyd V Jr
Jan/Feb 2001
Pg. 65-67

Compounding for Pediatric Patients: Case Reports and Formulations
Mixon William
, Angelle Patricea, Yoch Douglas
Jan/Feb 2009
Pg. 6-12

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions
Fonseca Simonne C
Nov/Dec 2005
Pg. 456-461

Basics of Compounding: Cosmetics for Special Populations and Using Cosmetics as Vehicles
Allen Loyd V Jr
Mar/Apr 2002
Pg. 102-105

Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Kochanowska-Karamyan Anna J
Sep/Oct 2016
Pg. 367-374

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene
, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Jan/Feb 2014
Pg. 6-12

Unlocking Autism: Is Compounding the Key?
Vail Jane
Nov/Dec 2005
Pg. 413-420

Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Giacoia George P
, Taylor-Zapata Perdita, Mattison Donald
May/Jun 2007
Pg. 220-225

Excipient Choices for Special Populations
Nagel-Edwards Karen M
, Ko James Y
Sep/Oct 2008
Pg. 426-430

Compounding for the Pediatric Patient
Allen Loyd V Jr
Mar/Apr 1997
Pg. 84-86

Goliath: Case Report on a Canine Case of Epilepsy
Ameijeiras Carlos
, Ray Jody, Jordan Dinah G, Garcia Abby Furr
Jan/Feb 2011
Pg. 27-31

Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Allen Loyd V Jr
May/Jun 2023
Pg. 223-229

Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis
Muller George
, Young Thomas W, Reina Rachel, Caldwell Delmar R
Jan/Feb 2010
Pg. 40-45

Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 502

Return to Top